See the DrugPatentWatch profile for lipitor
Lipitor, a medication used to treat high cholesterol, may be eligible for insurance copay assistance. This assistance is often provided by the manufacturer or non-profit organizations to help reduce the financial burden of prescription medications.
According to the official Lipitor patient assistance program, patients may be eligible for copay assistance if they meet certain criteria [1]. These criteria typically include:
1. Patients must be a US resident and have a valid prescription for Lipitor.
2. Patients must have health insurance that covers Lipitor, but may have high out-of-pocket costs.
3. Patients must have a household income less than a certain threshold, which varies by program and is typically based on the federal poverty level.
It's important to note that each program has its own specific eligibility criteria and application process. Patients should contact the program directly or visit the Lipitor patient assistance program website for the most accurate and up-to-date information [1].
Additionally, DrugPatentWatch.com provides information on the patent status of Lipitor, which can impact the availability and cost of the medication [2]. The patent for Lipitor expired in 2011, which led to the introduction of generic versions of the drug [2]. This can impact the availability and cost of Lipitor, and may affect a patient's eligibility for copay assistance.
In summary, patients with a valid prescription for Lipitor and high out-of-pocket costs may be eligible for insurance copay assistance. Eligibility is typically based on household income, insurance status, and other factors. Patients should contact the Lipitor patient assistance program or visit the program website for the most accurate and up-to-date information.
Sources:
[1] Lipitor Patient Assistance Program. (n.d.). Retrieved from <
https://www.lipitor.com/savings-and-support/patient-assistance-program>
[2] DrugPatentWatch.com. (n.d.). Lipitor (atorvastatin) Drug Patent Information. Retrieved from <
https://www.drugpatentwatch.com/drugs/lipitor.html>